Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Rehabilitation in transverse myelitis.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Neuroprotective effects of riluzole in neurotrauma models: a review.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Multiple sclerosis relapses and depression.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Substance Name: Dronabinol
Laquinimod Halted MS Disability But Not Relapses
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
MiR-126: a novel route for natalizumab action?
Pages
« first
‹ previous
…
128
129
130
131
132
133
134
135
136
…
next ›
last »